APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PREDICTING DISEASE PROGRESSION AND TREATMENT OUTCOMES
Keywords:
Artificial Intelligence, Cardiovascular Diseases, Chronic Kidney Disease, Clinical Decision Support Systems, Diabetes Mellitus, Forecasting, Machine Learning, Predictive Models, Precision Medicine, Treatment OutcomeAbstract
https://doi.org/10.71000/vkdxpa85
Background: Chronic diseases such as diabetes, chronic kidney disease (CKD), and cardiovascular disorders represent a significant burden on healthcare systems worldwide. Early prediction of disease progression and individualized treatment planning are essential for improving patient outcomes. Artificial intelligence (AI) offers promising tools to address these clinical challenges through predictive modeling and personalized care strategies.
Objective: To evaluate the effectiveness of AI in forecasting disease progression and optimizing treatment outcomes among patients with chronic conditions in a tertiary care setting.
Methods: This experimental quantitative study was conducted across tertiary care hospitals in Punjab, Pakistan, from January to August 2024. A total of 330 adult patients with type 2 diabetes, CKD, or cardiovascular disease were enrolled. Clinical data were extracted from electronic medical records, and predictive AI models were developed using supervised machine learning algorithms. Model performance was assessed via accuracy, sensitivity, specificity, and AUC-ROC. Treatment outcomes under AI-assisted care were compared with standard care using parametric statistical tests.
Results: AI models showed high predictive accuracy across conditions: diabetes (91.2%), CKD (88.5%), and CVD (86.4%). Strong agreement was observed between AI predictions and actual clinical outcomes (Cohen’s kappa >0.70 for all). AI-assisted care significantly improved clinical markers, including HbA1c reduction (1.4% vs 0.8%), slowed GFR decline (24.9% vs 16.5%), and greater LDL reduction (27.1 mg/dL vs 18.3 mg/dL), all with statistically significant differences (p<0.005).
Conclusion: AI has substantial potential in predicting disease trajectories and guiding more effective, patient-specific treatment strategies. These findings support its broader integration into precision medicine frameworks.
References
Dixon D, Sattar H, Moros N, Kesireddy SR, Ahsan H, Lakkimsetti M, et al. Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review. Cureus. 2024;16.
Reznichenko A, Nair V, Eddy S, Fermin D, Tomilo M, Slidel T, et al. Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine. Kidney Int. 2024;105(6):1263-78.
Egyud MRL, Holmes S, Burt BM. Technical Aspects of Robotic First Rib Resection. Thorac Surg Clin. 2023;33(3):265-71.
Costantino CL, Schumacher LY. Surgical Technique: Minimally Invasive First-Rib Resection. Thorac Surg Clin. 2021;31(1):81-7.
Pancholy SB, Shah SC, Patel TM. Safety and Efficacy of Robotic-Assisted PCI. Curr Cardiol Rep. 2022;24(7):817-21.
Mohsin S, Gapizov A, Ekhator C, Ain N, Ahmad S, Khan M, et al. The Role of Artificial Intelligence in Prediction, Risk Stratification, and Personalized Treatment Planning for Congenital Heart Diseases. Cureus. 2023;15.
Takebayashi T, Takahashi K, Amano S, Gosho M, Sakai M, Hashimoto K, et al. Robot-Assisted Training as Self-Training for Upper-Limb Hemiplegia in Chronic Stroke: A Randomized Controlled Trial. Stroke. 2022;53(7):2182-91.
Patil P, Patil K. A Review on Disease Prediction Using Artificial Intelligence. Journal Electrical and Computer Experiences. 2023.
Li Y, Shang K, Bian W, He L, Fan Y, Ren T, et al. Prediction of disease progression in patients with COVID-19 by artificial intelligence assisted lesion quantification. Scientific Reports. 2020;10.
Yousefi L, Tucker A. Predicting Type 2 Diabetes Complications and Personalising Patient Using Artificial Intelligence Methodology. Type 2 Diabetes [Working Title]. 2020.
Khalid F, Alsadoun L, Khilji F, Mushtaq M, Eze-Odurukwe A, Mushtaq MM, et al. Predicting the Progression of Chronic Kidney Disease: A Systematic Review of Artificial Intelligence and Machine Learning Approaches. Cureus. 2024;16.
Bonkhoff AK, Grefkes C. Precision medicine in stroke: towards personalized outcome predictions using artificial intelligence. Brain. 2022;145(2):457-75.
Murakami Y, Honaga K, Kono H, Haruyama K, Yamaguchi T, Tani M, et al. New Artificial Intelligence-Integrated Electromyography-Driven Robot Hand for Upper Extremity Rehabilitation of Patients With Stroke: A Randomized, Controlled Trial. Neurorehabil Neural Repair. 2023;37(5):298-306.
Huang KB, Gui CP, Xu YZ, Li XS, Zhao HW, Cao JZ, et al. A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nat Commun. 2024;15(1):6215.
Saliby RM, Labaki C, Jammihal TR, Xie W, Sun M, Shah V, et al. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes. Cancer Cell. 2024;42(5):732-5.
Nunes S, Sousa R, Serrano F, Branco R, Soares D, Martins A, et al. Explaining Artificial Intelligence Predictions of Disease Progression with Semantic Similarity. 2022:1256-68.
Liaw N, Liebeskind D. Emerging therapies in acute ischemic stroke. F1000Res. 2020;9.
Chae SH, Kim Y, Lee KS, Park HS. Development and Clinical Evaluation of a Web-Based Upper Limb Home Rehabilitation System Using a Smartwatch and Machine Learning Model for Chronic Stroke Survivors: Prospective Comparative Study. JMIR Mhealth Uhealth. 2020;8(7):e17216.
Cao Y, Shi Y, Hong W, Dai P, Sun X, Yu H, et al. Continuum robots for endoscopic sinus surgery: Recent advances, challenges, and prospects. Int J Med Robot. 2023;19(2):e2471.
Desideri F, Zinkernagel M, Anguita R. Artificial Intelligence in neovascular age-related macular degeneration. Klinische Monatsblatter fur Augenheilkunde. 2024.
Rajan A, Santhosh G, Manoj B, Manohar N, Anjali T. Artificial Intelligence in Healthcare: Predicting AIDS Progression with Machine Learning Models. 2024 8th International Conference on Electronics, Communication and Aerospace Technology (ICECA). 2024:747-53.
Chaudhuri S, Long A, Zhang H, Monaghan C, Larkin J, Kotanko P, et al. Artificial intelligence enabled applications in kidney disease. Seminars in Dialysis. 2020;34:5-16.
Wang T, Ugurlu H, Yan Y, Li M, Li M, Wild AM, et al. Adaptive wireless millirobotic locomotion into distal vasculature. Nat Commun. 2022;13(1):4465.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Tehreem Zahra, Umm e Aimen, Aqsa Hussain, Payal Harwani, Sana Ilyas, Fizza F. Farooqi, Humaira Mehwish, Mahum Tanweer (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
